Targeting NRG1-fusions in multiple tumour types: Afatinib as a novel potential treatment option Meeting Abstract


Authors: Liu, S. V.; Duruisseaux, M.; Tolba, K.; Branden, E.; Goto, Y.; Weinberg, B. A.; Renouf, D. J.; Doebele, R. C.; Heining, C.; Schlenk, R. F.; Cheema, P. K.; Cadranel, J.; Jones, M. R.; Drilon, A. E.; Trombetta, D.; Muscarella, L. A.; Cseh, A.; Solca, F.; Laskin, J. J.
Abstract Title: Targeting NRG1-fusions in multiple tumour types: Afatinib as a novel potential treatment option
Meeting Title: 44th ESMO Congress (ESMO 2019)
Journal Title: Annals of Oncology
Volume: 30
Issue: Suppl. 5
Meeting Dates: 2019 Sep 27-Oct 1
Meeting Location: Barcelona, Spain
ISSN: 0923-7534
Publisher: Oxford University Press  
Date Published: 2019-10-01
Start Page: mdz268.096
Language: English
ACCESSION: WOS:000491295505234
PROVIDER: wos
DOI: 10.1093/annonc/mdz268.096
Notes: Meeting Abstract: 1969P -- Appears on pages v791-v792 of the abstract book -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Alexander Edward Drilon
    632 Drilon